Your session is about to expire
← Back to Search
Circulation Evaluation Techniques for Sepsis (DAISY Trial)
DAISY Trial Summary
This trial aims to understand how eGC breakdown can influence HI to help develop better resuscitation treatments. HVM & biomarkers will be used to serially evaluate MiH & eGC.
DAISY Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DAISY Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the minimum age criteria for participants of this trial younger than 50 years?
"This experiment is only accepting participants aged between 18 and 99. In contrast, there are 37 trials for minors and 191 studies catering to elderly patients."
Is this research endeavor open to new participants?
"According to clinicaltrials.gov, this medical trial is still actively recruiting participants. The protocol was initially announced on July 1st 2022 and the details were most recently modified on January 13th 2023."
Is there a limit to the number of volunteers participating in this clinical trial?
"Confirmed. According to the information on clinicaltrials.gov, this research project is actively recruiting participants since its initial posting on July 1st 2022 and final update from January 13th 2023. A total of 150 patients are sought after by a single medical site."
Is participation in this trial open to the public?
"To qualify for this medical trial, potential participants must be between 18 and 99 years of age with a diagnosis of septic shock. A total of 150 persons are expected to take part in the study."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger